Hong Kong Shares Inch Up After China Holds Benchmark Rates Steady; Qyuns Therapeutics Falls 9% on Debut
Hong Kong Shares Inch Up After China Holds Benchmark Rates Steady; Qyuns Therapeutics Falls 9% on Debut
Hong Kong shares finished fractionally higher on Wednesday on encouraging corporate results, with traders keeping a watchful eye on the future direction of the People's Bank of China's monetary policy.
由于企业业绩令人鼓舞，香港股市周三收盘小幅上涨，交易员们密切关注中国人民银行货币政策的未来方向。
The Hang Seng Index climbed 0.08%, or 13.59 points, to finish the day's trade at 16,543.07. The Hang Seng China Enterprises Index (HSCEI) rose 0.41%, or 23.78 points, to 5,803.99.
恒生指数上涨0.08％，涨幅13.59点，收于16,543.07点。恒生中国企业指数（HSCEI）上涨0.41％，或23.78点，至5,803.99点。
Chinese banks have kept the one-year and five-year loan prime rates unchanged on Wednesday at 3.45% and 3.95%, respectively. It follows the central bank's decision to keep the one-year, medium-term lending rate at 2%. PBoC Governor Pan Gongsheng has said the nation has "ample monetary policy space" and a "deep toolbox" to accomplish its goals.
中国银行周三将一年期和五年期贷款最优惠利率分别维持在3.45％和3.95％不变。在此之前，央行决定将一年期中期贷款利率维持在2％。中国人民银行行长潘功胜曾表示，该国有 “充足的货币政策空间” 和 “深度工具箱” 来实现其目标。
In corporate news, China Unicom Hong Kong (HKG:0762) advanced some 2% after the telco posted a record income for 2023.
在企业新闻方面，中国联通香港（HKG: 0762）上涨了约2％，此前该电信公司公布了2023年创纪录的收入。
Li Ning (HKG:2331) gained about 6% after the homegrown sportswear maker reported higher revenue for 2023.
李宁（HKG: 2331）上涨约6％，此前这家本土运动服制造商报告2023年收入增加。
Meanwhile, drugmaker Qyuns Therapeutics (HKG:2509) lost over 9% on its market debut.
同时，制药商Qyuns Therapeutics（HKG: 2509）在首次上市时下跌了9％以上。